Comparison of safety and efficacy of posterior lumbar interbody fusion (PLIF) and modified transforaminal lumbar interbody fusion (M-TLIF) in the treatment of single-segment lumbar degenerative diseases

Table 5 Comparison of postoperative complications

	PLIF (n = 74)	M-TLIF (n = 74)	P
Dural tear, n (%)			1.000
No	72 (97.30%)	73 (98.65%)
Yes	2 (2.70%)	1 (1.35%)
Stroke, n (%)			1.000*
No	73 (98.65%)	74 (100%)
Yes	1 (1.35%)	0
Respiratory tract infection, n (%)			1.000*
No	74 (100%)	73 (98.65%)
Yes	0	1 (1.35%)
Urinary tract infection, n (%)			0.612
No	71 (95.95%)	73 (98.65%)
Yes	3 (4.05%)	1 (1.35%)
Deep venous thrombosis, n (%)			NA
No	74 (100%)	74 (100%)
Yes	0	0
The wound surface healed poorly n (%)			1.000
No	66 (89.19%)	67 (90.54%)
Yes	8 (10.81%)	7 (9.46%)
Deep infection at surgical site, n (%)			0.363
No	70 (94.59%)	73 (98.65%)
Yes	4 (5.41%)	1 (1.35%)
Screw loose or broken, n (%)			1.000
No	73 (98.65%)	73 (98.65%)
Yes	1 (1.35%)	1 (1.35%)
Intraspinal hematoma, n (%)			0.028*
No	68 (91.89%)	74 (100%)
Yes	6 (8.11%)	0
There are contralateral nerve root symptoms n (%)			1.000*
No	73 (98.65%)	74 (100%)
Yes	1 (1.35%)	0

*Results from fisher’s exact test. PLIF, Posterior lumbar interbody fusion. M-TLIF, Modified transforaminal lumbar interbody fusion

ISSN: 1749-799X